View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Rituximab 375, Hodgkin Lymphoma, Cycle 1-4
Protocol-ID: 2360 V1.0 (Mini), RITU375, Hodgkin, C1-4Indication(s)
- Hodgkin Lymphoma (Nodular lymphocyte-predominant (NLPHL)); ICD-10 C81.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 11.06.2023